Basal Cell Adenoma of Zygomatic Salivary Gland in a Young Dog – First Case Report in Mozambique

Total Page:16

File Type:pdf, Size:1020Kb

Basal Cell Adenoma of Zygomatic Salivary Gland in a Young Dog – First Case Report in Mozambique RPCV (2015) 110 (595-596) 229-232 Basal cell adenoma of zygomatic salivary gland in a young dog – First case report in Mozambique Adenoma das células basais da glândula salivar zigomática em cão jovem – Primeiro relato de caso em Moçambique Ivan F. Charas dos Santos*1,2, José M.M. Cardoso1, Giovanna C. Brombini3 Bruna Brancalion3 1Departamento de Cirurgia, Faculdade de Veterinária, Universidade Eduardo Mondlane, Maputo, Moçambique 2Pós-doutorando (Bolsista FAPESP), Departamento de Cirurgia e Anestesiologia Veterinária, Faculdade de Medicina Veterinária e Zootecnia (FMVZ), Universidade Estadual Paulista (UNESP), Botucatu, São Paulo, Brasil. 3Faculdade de Medicina Veterinária e Zootecnia (FMVZ), Universidade Estadual Paulista (UNESP),Botucatu, São Paulo, Brasil. Summary: Basal cell adenoma of zygomatic salivary gland Introduction was described in a 1.2 years old Rottweiler dog with swelling of right zygomatic region tissue. Clinical signs were related to Salivary glands diseases in small animals include anorexia, slight pain on either opening of the mouth. Complete blood count, serum biochemistry, urinalysis, thoracic radio- mucocele, salivary gland fistula, sialadenitis, sialad- graphic examination; and transabdominal ultrasound showed enosis, sialolithiasis and less neoplasia (Spangler and no alteration. The findings of cytology examination were con- Culbertson, 1991; Johnson, 2008). Primary tumours sistent with benign tumour and surgical treatment was elected. of salivary glands are rare in dogs and not common- The histopathologic examinations were consistent with basal ly reported in small animals. The incidence is about cell adenoma of zygomatic salivary gland. Seven days after the surgery no alteration was observed. One year later, the dog re- 0.17% in dogs with age between 10 and 12 years turned to check up and confirmed that the dog was healthy and old (Spangler and Culbertson, 1991; Hammer et al., free of clinical and laboratorial signs of tumour recurrence or 2001; Head and Else, 2002). Overall incidence is 1.6 metastases. Reports of basal cell adenoma of salivary gland in benign tumours per 100,000 dogs at risk (Head and young dogs were lack on the veterinary literature. To author’s Else, 2002). knowledge, this was the first report of clinical and surgery de- scription of basal cell adenoma of zygomatic salivary gland in Adenocarcinomas of salivary gland are more com- a young dog in Mozambique. mon than adenomas in dogs and cats, and represent 5% of all salivary gland tumours. Overall incidence Keywords: Dog, epithelial cells, salivary gland, tumour. is 3.1 per 100,000 dogs at risk (Spangler and Cul- bertson, 1991; Hammer et al., 2001; Head and Else, Resumo: Adenoma das células basais de glândula salivar zigo- mática foi descrito em cão da raça Rottweiler, macho, 1,2 anos 2002). No breeder or sex predilection is reported de idade, pesando 38 kg, com tumefação da região zigomática (Hammer et al., 2001; Head and Else, 2002) and pa- direita. Os sinais clínicos foram relacionados com anorexia e rotid and mandibular salivary glands are most affect- dor ligeira durante a abertura da boca. O hemograma, exame ed and represent 75 - 80%, respectively (Hammer et bioquímico sérico, urinálise, exame radiográfico de tórax, e al., 2001). Furthermore, the zygomatic salivary gland ultrassonografia transabdominal não demonstraram alteração. O exame citológico foi compatível com tumor benigno e o tra- is not frequently affected by tumours (Spangler and tamento foi o procedimento cirúrgico. O exame histopatológi- Culbertson, 1991). co foi consistente com adenoma das células basais de glândula Clinical signs of salivary gland tumour are non- salivar zigomática. Sete dias após a cirurgia não foi observado specific. However, owner´s reported swollen, pain, alterações. Um ano mais tarde, o animal retornou para” check- anorexia and exophthalmia (Hammer et al., 2001; up” e foi confirmado que o mesmo apresentava-se saudável e livre de sinais clínicos e laboratoriais de recorrência ou metás- Smrkovski et al., 2006; Johnson, 2008). The differen- tase tumoral. Referências sobre o adenoma de células basais tials diagnostic include sebaceous adenoma (Oh and de glândula salivar zigomática em cães jovens são escassas na Eisele, 2006), clear cell variant of acinic cell carcino- literatura veterinária. De acordo com o conhecimento dos auto- ma (Brunnert and Altman, 1990), epithelial-myoepi- res, este foi o primeiro relato de descrição clínica e cirúrgica do thelial carcinoma (Sozmen et al., 1998), salivary duct adenoma de células basais de glândula salivar zigomática em cão jovem, em Moçambique. carcinoma (Sozmen et al., 1999) and sebaceous carci- noma (Sozmen et al., 2002). Palavras-chave: Cão, células epiteliais, glândula salivar, tumor. To the authors’ knowledge, reports about basal cell adenoma of zygomatic salivary gland in young *Correspondência: [email protected] dogs are rare in the veterinary literature and no re- Tel.: +55 14 98183-7166 229 Santos I. et al. RPCV (2015) 110 (595-596) 230-232 ports of description of basal cell adenoma of zygo- anaplasia could not be observed. Features were sug- matic salivary gland in a young dog in Mozambique gestive of basal cell adenoma. However, histopatholo- were done. The present case report describes the gical examination was advised to confirm the diagno- clinical and surgery aspects of basal cell adenoma sis and surgical treatment was elected. Bacterial and of zygomatic salivary gland in a dog with 1.2 years fungal culture was negative. old attended at School Veterinary Hospital, Maputo, Patient underwent mass and right zygomatic sa- Mozambique. livary gland extirpation. The dog was premedicated with carprofen (4.4 mg/kg subcutaneous [SC]), mor- Case report phine (0.3 mg/kg SC), acepromazine (0.05 mg/kg SC). Anaesthesia was done with propofol (2.5 mg/ kg An 1.2 years old neutered male Rottweiler dog, intravenous [IV]) and halothane. The animal was pla- weighting 38 kg was attended at School Veterinary ced in left lateral recumbence and a modified lateral Hospital, Maputo, Mozambique, referred for eva- ellipse surgical approach was performed on zygoma- luation of a three months history of swelling of ri- tic salivary gland region and a marginal resection of 3 ght zygomatic region. The owner also reported fast cm of the mass was done and both zygomatic salivary swelling on the first two weeks. No history of trauma gland and mass were removed. A capsule around the was reported and owner´s complaint was related ano- tumour was observed. The skin was apposed with 3-0 rexia. nylon simple isolate sutures (Figure 2A and 2B). Physical examination revealed a well circumscri- bed swelling, measuring approximately 8 cms in dia- meter on right zygomatic region. The swelling was well defined, firm and tender and was fixed to the underlying structures. No pain was revealed but slight pain on either opening of the mouth was observed. Other physical examination parameters were otherwi- se unremarkable. Complete blood count, serum bio- chemistry (alanine aminotransferase – ALT, aspartate aminotransferase – AST, blood urea nitrogen – BUN, Figure 2 - Photography showing a mass in zygomatic salivary alkaline phosphatase, total protein, albumin, globulin gland (white arrows) and capsule (yellow arrow) (a), and skin and creatine kinase – CK) and urinalysis were perfor- sutures (b). med and showed no alteration. Thoracic radiographic Postoperatively, was prescribed cephalexin (25 examination and transabdominal ultrasound were per- mg/kg per os [PO] q12h) for 10 days and carprofen formed and showing no alteration. The radiographic (4.4 mg/kg PO q24h) for 5 days. examination of the head showed an enlargement of Mass sections were fixed in 10% neutral buffered the right zygomatic salivary gland region (Figure 1A formalin, embedded in paraffin, cut through transver- and 1B). sal and sagittal planes in 5 μm thick sections, staining haematoxylin–eosin (H&E) and examined by light microscopy. The mass revealed a white partially en- capsulated soft tissue, measuring 8 cms of diameter. The outer surface was nodular and cut section was lo- bular. Microscopically, the section showed thick bran- ching cords and irregular islands of epithelial cells, with indistinct cell borders, separated by fibrous tis- sue stroma and forming small glandular structures. Nuclei were rounded; with infrequent mitoses and low mitotic rate (Figure 3). Figure 1 - Photograph showing swelling of 8 cm diameters of right zygomatic region (a). Radiographic exam of the head Where observed irregular tumour margins, locally and enlargement of right zygomatic gland region soft tissue infiltrative growth and portions of non-neoplasic sa- (arrow) (b). livary gland tissue. Encapsulation could not be iden- tified. Those findings were consistent with basal cell Fine needle aspiration cytology (FNAC) was done adenoma of zygomatic salivary gland. from the right zygomatic region. Small quantity of Seven days after the surgery, skin suture was re- serosanguineous material was observed. Smear sho- moved and no alteration was observed. One year later, wed cellular smears comprising of neutrophilic cells, the dog returned to check up and confirmed that the erythrocytes and monomorphic and small round-to- dog was healthy and free of clinical signs of tumour oval cells showing few pleomorphism, eosinophil recurrence or metastases by transabdominal ultra- cytoplasm and elongate nucleus. Mitotic figures and sound and chest radiography examination. 230 Santos I. et al. RPCV
Recommended publications
  • Glossary for Narrative Writing
    Periodontal Assessment and Treatment Planning Gingival description Color: o pink o erythematous o cyanotic o racial pigmentation o metallic pigmentation o uniformity Contour: o recession o clefts o enlarged papillae o cratered papillae o blunted papillae o highly rolled o bulbous o knife-edged o scalloped o stippled Consistency: o firm o edematous o hyperplastic o fibrotic Band of gingiva: o amount o quality o location o treatability Bleeding tendency: o sulcus base, lining o gingival margins Suppuration Sinus tract formation Pocket depths Pseudopockets Frena Pain Other pathology Dental Description Defective restorations: o overhangs o open contacts o poor contours Fractured cusps 1 ww.links2success.biz [email protected] 914-303-6464 Caries Deposits: o Type . plaque . calculus . stain . matera alba o Location . supragingival . subgingival o Severity . mild . moderate . severe Wear facets Percussion sensitivity Tooth vitality Attrition, erosion, abrasion Occlusal plane level Occlusion findings Furcations Mobility Fremitus Radiographic findings Film dates Crown:root ratio Amount of bone loss o horizontal; vertical o localized; generalized Root length and shape Overhangs Bulbous crowns Fenestrations Dehiscences Tooth resorption Retained root tips Impacted teeth Root proximities Tilted teeth Radiolucencies/opacities Etiologic factors Local: o plaque o calculus o overhangs 2 ww.links2success.biz [email protected] 914-303-6464 o orthodontic apparatus o open margins o open contacts o improper
    [Show full text]
  • A Primary Parotid Mucosa-Associated Lymphoid Tissue Non-Hodgkin Lymphoma in a Patient with Sjogren Syndrome
    Open Access Case Report DOI: 10.7759/cureus.15679 A Primary Parotid Mucosa-Associated Lymphoid Tissue Non-Hodgkin Lymphoma in a Patient With Sjogren Syndrome Michael R. Povlow 1 , Mitchell Streiff 2 , Sunthosh Madireddi 1 , Couger Jaramillo 3 1. Department of Radiology, Brooke Army Medical Center, San Antonio, USA 2. Department of Radiology, Ponce Health Sciences University, Ponce, USA 3. Department of Pathology, Brooke Army Medical Center, San Antonio, USA Corresponding author: Michael R. Povlow, [email protected] Abstract The salivary gland tumors are rare entities and the majority of these are benign. However, there are some entities such as prior neck radiation, certain infections, and systemic diseases which should raise the clinical suspicion for a malignant lesion. Patients with Sjogren syndrome are at increased risk for a salivary gland neoplasm, specifically non-Hodgkin lymphoma. While clinical findings play an important role in the initial workup, imaging plays a critical role in the diagnosis and management. This case describes a patient with Sjogren syndrome who presented with a left face mass where imaging was able to confidently diagnose her with a suspicious parotid neoplasm with lymphoma as the favored diagnosis. After histological evaluation, she was diagnosed with primary parotid mucosa-associated lymphoid tissue (MALT) non-Hodgkin lymphoma after which she went on to non-operative management. Categories: Otolaryngology, Pathology, Radiology Keywords: parotid tumor, non-hodgkin’s lymphomas, salivary gland neoplasm, mucosa-associated lymphoid tissue (malt), head and neck neoplasms, head and neck radiology, sjogren's Introduction The salivary gland tumors are rare, accounting for only 6-8% of all head and neck tumors annually in the United States [1].
    [Show full text]
  • Diseases of Salivary Glands: Review
    ISSN: 1812–1217 Diseases of Salivary Glands: Review Alhan D Al-Moula Department of Dental Basic Science BDS, MSc (Assist Lect) College of Dentistry, University of Mosul اخلﻻضة امخجوًف امفموي تُئة رطبة، حتخوي ػىل طبلة ركِلة من امسائل ثدغى انوؼاب ثغطي امسطوح ادلاخوَة و متﻷ امفراغات تني ااطَة امفموًة و اﻷس نان. انوؼاب سائل مؼلد، ًنذج من امغدد انوؼاتَة، اذلي ًوؼة دورا" ىاما" يف اﶈافظة ػىل سﻻمة امفم. املرىض اذلٍن ؼًاهون من هلص يف اﻷفراز انوؼايب حكون دلهيم مشبلك يف اﻷلك، امخحدث، و امبوع و ًطبحون غرضة مﻷههتاابت يف اﻷغش َة ااطَة و امنخر املندرش يف اﻷس نان. ًوخد ثﻻثة أزواج من امغدد انوؼاتَة ام ئرُسة – امغدة امنكفِة، امغدة حتت امفكِة، و حتت انوساهَة، موضؼيا ٍكون خارج امخجوًف امفموي، يف حمفظة و ميخد هظاهما املنَوي مَفرغ افرازاهتا. وًوخد أًضا" امؼدًد من امغدد انوؼاتَة امطغرية ، انوساهَة، اتحنكِة، ادلىوزيًة، انوساهَة احلنكِة وما كبل امرخوًة، ٍكون موضؼيا مﻷسفل و مضن امغشاء ااطي، غري حماطة مبحفظة مع هجاز كنَوي كطري. افرازات امغدد انوؼاتَة ام ئرُسة مُست مدشاهبة. امغدة امفكِة ثفرز مؼاب مطيل غين ابﻷمِﻻز، وامغدة حتت امفكِة ثنذج مؼاب غين اباط، أما امغدة حتت انوساهَة ثنذج مؼااب" مزخا". ثبؼا" ميذه اﻷخذﻻفات، انوؼاب املوحود يق امفم ٌشار امَو مكزجي. ح كرَة املزجي انوؼايب مُس ثس َطا" واملادة اﻷضافِة اموػة من لك املفرزات انوؼاتَة، اكمؼدًد من امربوثُنات ثنذلل ثرسػة وثوخطق هبدروكس َل اﻷتُذاًت مﻷس نان و سطوح ااطَة امفموًة. ثبدأ أمراض امغدد انوؼاتَة ػادة تخغريات اندرة يف املفرزات و ام كرتَة، وىذه امخغريات ثؤثر اثهواي" من خﻻل جشلك انووحية اجلرثومِة و املوح، اميت تدورىا ثؤدي اىل خنور مذفش َة وأمراض وس َج دامعة. ىذه اﻷمراض ميكن أن ثطبح شدًدة تؼد املؼاجلة امشؼاغَة ﻷن امؼدًد من احلاﻻت اجليازًة )مثل امسكري، امخوَف اهكُيس( ثؤثر يف اجلراين انوؼايب، و ٌش خيك املرض من حفاف يف امفم.
    [Show full text]
  • ICD-9 Diagnosis Codes Effective 10/1/2011 (V29.0) Source: Centers for Medicare and Medicaid Services
    ICD-9 Diagnosis Codes effective 10/1/2011 (v29.0) Source: Centers for Medicare and Medicaid Services 0010 Cholera d/t vib cholerae 00801 Int inf e coli entrpath 01086 Prim prg TB NEC-oth test 0011 Cholera d/t vib el tor 00802 Int inf e coli entrtoxgn 01090 Primary TB NOS-unspec 0019 Cholera NOS 00803 Int inf e coli entrnvsv 01091 Primary TB NOS-no exam 0020 Typhoid fever 00804 Int inf e coli entrhmrg 01092 Primary TB NOS-exam unkn 0021 Paratyphoid fever a 00809 Int inf e coli spcf NEC 01093 Primary TB NOS-micro dx 0022 Paratyphoid fever b 0081 Arizona enteritis 01094 Primary TB NOS-cult dx 0023 Paratyphoid fever c 0082 Aerobacter enteritis 01095 Primary TB NOS-histo dx 0029 Paratyphoid fever NOS 0083 Proteus enteritis 01096 Primary TB NOS-oth test 0030 Salmonella enteritis 00841 Staphylococc enteritis 01100 TB lung infiltr-unspec 0031 Salmonella septicemia 00842 Pseudomonas enteritis 01101 TB lung infiltr-no exam 00320 Local salmonella inf NOS 00843 Int infec campylobacter 01102 TB lung infiltr-exm unkn 00321 Salmonella meningitis 00844 Int inf yrsnia entrcltca 01103 TB lung infiltr-micro dx 00322 Salmonella pneumonia 00845 Int inf clstrdium dfcile 01104 TB lung infiltr-cult dx 00323 Salmonella arthritis 00846 Intes infec oth anerobes 01105 TB lung infiltr-histo dx 00324 Salmonella osteomyelitis 00847 Int inf oth grm neg bctr 01106 TB lung infiltr-oth test 00329 Local salmonella inf NEC 00849 Bacterial enteritis NEC 01110 TB lung nodular-unspec 0038 Salmonella infection NEC 0085 Bacterial enteritis NOS 01111 TB lung nodular-no exam 0039
    [Show full text]
  • Monomorphic Adenoma: a Diagnosis Or a Misnomer? a Review of Literature on Terminologies, Features and Differential Diagnosis of Basal Cell Adenoma
    Acta Scientific DENTAL SCIENCES (ISSN: 2581-4893) Volume 5 Issue 1 January 2021 Research Article Monomorphic Adenoma: A Diagnosis or a Misnomer? A Review of Literature on Terminologies, Features and Differential Diagnosis of Basal Cell Adenoma Swati Gupta1, Ramakant Gupta2* and Manju Gupta3 Received: December 01, 2020 1Senior Consultant, Oral and Maxillofacial Pathology, Dr. Jatinder Gupta’s Gupta Published: Clinic and Opticals, Haryana, India © All rights are reserved by Ramakant 2Head and Consultant, Department of Dental Services, Dr. Jatinder Gupta’s Gupta December 29, 2020 Gupta., et al. Clinic and Opticals, Haryana, India 3Director and Clinic coordinator, Dr. Jatinder Gupta’s Gupta Clinic and Opticals, Haryana, India *Corresponding Author: Ramakant Gupta, Head and Consultant, Department of Dental Services, Dr. Jatinder Gupta’s Gupta Clinic and Opticals, Haryana, India. Abstract Basal cell adenoma, previously was termed by few authors as Monomorphic adenoma. The term “Monomorphic adenoma” was originally proposed for any benign epithelial salivary gland tumour other than benign mixed tumors. Monomorphic adenoma includ- salivary gland tumours the term “monomorphic adenoma” is not included and basal cell adenoma is considered as a separate entity. ed tumours such as Warthins tumour, basal cell adenoma and canalicular adenoma. However, in the new 2005 WHO classification of diagnosis and differentiation of basal cell adenoma from other tumours. This paper intends to discuss the controversies regarding the terminology and classification of monomorphic adenoma along with Keywords: Adenoid Cystic Carcinoma; Basal Cell Adenoma; Basal Cell Carcinoma; Canalicular Adenoma; Epithelial Salivary Gland Tumour; Monomorphic Adenoma; WHO Classification Abbreviations to controversies. The term “monomorphic adenoma” was original- ly proposed for any benign epithelial salivary gland tumour other ACC: Adenoid Cystic Carcinoma; BCA: Basal Cell Adenoma; BCC: than benign mixed tumours by Rouch in 1970 [7].
    [Show full text]
  • Classification of Salivary Gland Disorders
    Salivary Gland Diseases and Disorders Dr. Mahmoud E. Khalifa Prof of OMFS Lecture ILOs At the end of this chapter you should be able to: 1. Distinguish the clinical features of infections of the salivary glands from those in other structures 2. Differentiate on clinical grounds between infection, obstruction, benign and malignant neoplasms of the salivary glands 3. Plan and evaluate the results of the investigation of disorders of the salivary glands 4. List the important/relevant information to be elicited from patients with salivary gland disorders 5. Select cases which require referral for a specialist opinion 6. Describe the causes of a dry mouth and be able to distinguish between organic and functional causes. Anatomy Major glands Minor glands 3 pairs Situated mostly 800 to 1000 in the oral cavity Parotid Submandibular The majority atAlso found in the the junction of pharynx, larynx, the hard and soft trachea, and palates sinuses sublingual Functions These glands function to produce saliva, which serves as Lubricant for speech & swallowing Assists taste Immunologic (antibacterial) Digestive Cleansing properties Based on the type of secretion, the salivary glands may be grouped as: (i) Serous, (ii) Mucous and (iii) Mixed. Parotid gland secretion is serous in nature. The sublingual gland secretes mixed, but predominantly mucous. The submandibular gland secretion is also mixed, but is predominantly serous. The minor glands secrete mucous saliva. Parotid Gland The parotid gland is the largest salivary gland, the secretion of which is serous in nature. It is pyramidal in shape; The base located superficial and apex medially The base is triangular in shape its apex is towards the angle of the mandible, the base at the external acoustic meatus The parotid duct (Stenson‘s duct) Emerges at the anterior part of the gland.
    [Show full text]
  • Basal Cell Adenoma of the Upper Lip: a Case Report
    Journal of Dental Health Oral Disorders & Therapy Case Report Open Access Basal cell adenoma of the upper lip: a case report Abstract Volume 2 Issue 4 - 2015 Purpose: We report the case of an 84 year old male who had been complaining of a slow Abdul Basit Karim,1 Lhara Sumarriva,2 growing painless mass on the upper lip. Adequate preoperative imaging and differential 2 1 diagnosis is paramount before proceeding with surgical intervention. Abdelsalam Sharabi, Takehiro Kasahara 1Department of Oral and Maxillofacial Surgery, Army College of Materials and methods: Hematoxylin-Eosin staining Dental Sciences, India 2Department of Pathology, Mount Sinai St. Luke’s-Roosevelt Results: Histopathological examination of the specimen was significant for basal cell Hospital, USA adenoma. Correspondence: Abdul Basit Karim, DDS, Mount Sinai St Conclusion: Suspicion of malignancy in an upper lip mass is low. Most often, an upper lip Luke’s-Roosevelt Hospital, 1111 Amsterdam Ave. Minturn 205 mass would be canalicular adenoma. Basal cell adenoma is most common in the parotid New York, NY 1002, USA, Tel 212 523 3171, gland and rarely presents in the upper lip. Email Keywords: Salivary gland, pleomorphic adenoma, Parotid gland, neoplasms, pleomorphic Received: May 15, 2015 | Published: June 18, 2015 Introduction pattern and the solid component with small uniform basal cells (Figure 9,10). Salivary gland tumors are uncommon neoplasms, comprising of 2 to 6 percent of all head and neck tumors.1,2 The majority occur in major salivary glands, specifically the parotid gland. Pleomorphic adenomas are the most common benign tumors of salivary glands and occur mainly in the parotid gland.
    [Show full text]
  • Case Report of Basal Cell Adenocarcinoma of the Parotid Gland: Clinicopathological and Immunohistochemical Study
    Case report of Basal cell adenocarcinoma of the parotid gland: clinicopathological and immunohistochemical study García Pedro Emilio1, Avila Rodolfo Esteban2, Samar María Elena3 DOI: 10.22592/ode2018n31a8 Abstract Basal cell adenocarcinoma is an epithelial neoplasm with the cytological characteristics of basal cell adenoma but with a morphological pattern of infiltrative growth indicative of malignancy. Due to its low incidence it is often difficult to diagnose a basal cell adenocarcinoma. The objective of the present study was to identify morphological and immunohistochemical characteristics that contribute to its diagnosis. A parotid tumor was resected in a 52-year-old patient; postoperative biopsy and immunostaining with Ki-67, CK19, p63 and alpha- smooth muscle actin were performed. It was diagnosed basal cell adenocarcinoma that invades the tumor capsule, periglandular fat and lymph nodes. Immunostaining with Ki-67, CK19, p63 and alpha- smooth muscle actin was positive. Subsequently, a maxillary sinus metastasis was diagnosed. The morphological characteristics, Ki-67 expression strongly positive and metastasis give the malignant character to this tumor, which differentiates it from the basal cell adenoma. Keywords: parotid, basal cell adenocarcinoma, diagnosis. 1 Medical Doctor - Clinical Oncology Specialist. Assistant Professor. School of Medical Sciences. Universidad Nacional de Córdoba. Argentina. ORCID: 0000-0001-5268-2339 2 Doctor of Medicine and Surgery. Associate Professor. School of Medical Sciences. Universidad Nacional
    [Show full text]
  • Salivary Gland Pathology Salivary Gland Pathology 2007 June Cheng-Chung Lin Prof
    Salivary Gland Pathology Salivary Gland Pathology 2007 June Cheng-Chung Lin Prof. in Oral Pathology Kaohsiung Med University E-mail: [email protected] Histological Classification of Salivary Gland Tumors (WHO) 1. Adenomas 2.13. Malignant myoepithelioma 1.2. Pleomorphic Adenoma 2.14. Carcinoma in PA 1.3. Basal cell adenoma (Malignant mixed tumor) 1.4. Warthin tumor 2.15. Squamous cell carcinoma 1.5. Oncocytoma(Oncocytic adenoma) 2.16. Small cell carcinoma 1.6. Canalicular adenoma 2.17. Undifferentiated carcinoma 1.7. Sebaceous adenoma 2.18. Other carcinomas 1.8. Ductal papilloma 3. Non-epithelial tumors 1.8.1 Inverted ductal papilloma 4. Malignant Lymphomas 1.8.2. Intraductal papilloma 5. Secondary tumors 1.8.3. Sialadenoma papilliferum 6. Unclassified tumors 1.9. Cystadenoma 7. Tumor-like lesions 1.9.1. Papillary cystadenoma 7.1. Sialadenosis 1.9.2. Mucinous cystadenoma 7.2. Oncocytosis 2. Carcinomas 7.3. Necrotizing sialometaplasia 7.4. Benign lymphoepithelial lesion 2.2. Mucoepidermoid carcinoma 7.5. Salivary gland cysts 2.3. Adenoid cystic carcinoma 7.6. Chronic sclerosing sialadenitis of sub- mandibular gland (Kuttner tumor) 2.4. Polymorphous low grade 7.7. Cystic lymphoid hyperplasia in AIDS Adenocarcinoma (PLGA) 2.5. Epithelial-myoepithelial carcinoma 2.6. Basal cell adenocarcinoma 2.7. Sebaceous carcinoma 2.8. Papillary cystadenocarcinoma 2.9. Mucinous adenocarcinoma 2.10. Oncocytic carcinoma 2.11. Salivary duct carcinoma 2.12. Adenocarcinoma, NOS 1 Salivary Gland Pathology While the clinical presentation of a salivary gland tumor (SGT) is usually an asymptomatic mass that may occasionally be ulcerated or cause pain, the histologic presentation is far more complex.
    [Show full text]
  • Statistical Analysis Plan
    Cover Page for Statistical Analysis Plan Sponsor name: Novo Nordisk A/S NCT number NCT03061214 Sponsor trial ID: NN9535-4114 Official title of study: SUSTAINTM CHINA - Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin in subjects with type 2 diabetes Document date: 22 August 2019 Semaglutide s.c (Ozempic®) Date: 22 August 2019 Novo Nordisk Trial ID: NN9535-4114 Version: 1.0 CONFIDENTIAL Clinical Trial Report Status: Final Appendix 16.1.9 16.1.9 Documentation of statistical methods List of contents Statistical analysis plan...................................................................................................................... /LQN Statistical documentation................................................................................................................... /LQN Redacted VWDWLVWLFDODQDO\VLVSODQ Includes redaction of personal identifiable information only. Statistical Analysis Plan Date: 28 May 2019 Novo Nordisk Trial ID: NN9535-4114 Version: 1.0 CONFIDENTIAL UTN:U1111-1149-0432 Status: Final EudraCT No.:NA Page: 1 of 30 Statistical Analysis Plan Trial ID: NN9535-4114 Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin in subjects with type 2 diabetes Author Biostatistics Semaglutide s.c. This confidential document is the property of Novo Nordisk. No unpublished information contained herein may be disclosed without prior written approval from Novo Nordisk. Access to this document must be restricted to relevant parties.This
    [Show full text]
  • 1 Surgical Pathology of the Mouth and Jaws R. A. Cawson, J. D. Langdon
    Surgical pathology of the mouth and jaws R. A. Cawson, J. D. Langdon, J. W. Eveson 12. Tumours of salivary glands A great variety of neoplasms can form in the salivary gland tissues. The classification of Thackray and Sobin (1972) (Table 12.1) is still widely used, but inevitably has been overtaken by the recognition of new types of tumours. A modified classification broadly based on changes proposed by the WHO Collaborating Center for Salivary Gland Tumors is therefore shown in Table 12.2, but even so it is not always easy to fit a particular tumour into one of these many categories. Non-neoplastic diseases have been discussed in the previous chapter, but in the parotid gland particularly it is not always possible to distinguish them from neoplasms preoperatively. Table 12.1 Classification of salivary gland tumours (After Thackray and Sobin, 1972) Epithelial A. Adenomas 1. Pleomorphic adenoma (mixed tumour) 2. Monomorphic adenoma (a) Adenolymphoma (Warthin's tumour) (b) Oxyphilic adenoma (oncocytoma) (c) Other monomorphic adenomas B. Mucoepidermoid tumour C. Acinic cell tumour D. Carcinomas 1. Adenoid cystic carcinoma 2. Adenocarcinoma 3. Squamous cell carcinoma 4. Undifferentiated carcinomas 5. Carcinoma in pleomorphic adenoma Non-Epithelial Haemangioma Lymphangioma Neurofibroma Lipoma Others including malignant varieties of the above Lymphoma. Age, site and sex distribution in relatin to tumour type In the British Salivary Gland Tumour Panel series of more than 3500 unselected tumours, there is a wide age distribution, but the peak incidence for benign tumours is in the sixth decade and, for malignant tumours, the seventh. Thus in the third decade, nearly 95% of tumours are benign, but by the seventh decade and after, 30% of tumours are malignant.
    [Show full text]
  • Description Concept ID Synonyms Definition
    Description Concept ID Synonyms Definition Category ABNORMALITIES OF TEETH 426390 Subcategory Cementum Defect 399115 Cementum aplasia 346218 Absence or paucity of cellular cementum (seen in hypophosphatasia) Cementum hypoplasia 180000 Hypocementosis Disturbance in structure of cementum, often seen in Juvenile periodontitis Florid cemento-osseous dysplasia 958771 Familial multiple cementoma; Florid osseous dysplasia Diffuse, multifocal cementosseous dysplasia Hypercementosis (Cementation 901056 Cementation hyperplasia; Cementosis; Cementum An idiopathic, non-neoplastic condition characterized by the excessive hyperplasia) hyperplasia buildup of normal cementum (calcified tissue) on the roots of one or more teeth Hypophosphatasia 976620 Hypophosphatasia mild; Phosphoethanol-aminuria Cementum defect; Autosomal recessive hereditary disease characterized by deficiency of alkaline phosphatase Odontohypophosphatasia 976622 Hypophosphatasia in which dental findings are the predominant manifestations of the disease Pulp sclerosis 179199 Dentin sclerosis Dentinal reaction to aging OR mild irritation Subcategory Dentin Defect 515523 Dentinogenesis imperfecta (Shell Teeth) 856459 Dentin, Hereditary Opalescent; Shell Teeth Dentin Defect; Autosomal dominant genetic disorder of tooth development Dentinogenesis Imperfecta - Shield I 977473 Dentin, Hereditary Opalescent; Shell Teeth Dentin Defect; Autosomal dominant genetic disorder of tooth development Dentinogenesis Imperfecta - Shield II 976722 Dentin, Hereditary Opalescent; Shell Teeth Dentin Defect;
    [Show full text]